Back to calendar
Evommune, Inc. (EVMN) Earnings
EVMN reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.83
Actual EPS: $-0.89
EPS surprise: -33.94%
Company overview
Market Cap$507.1M
PriceUSD 14.08
EPS (TTM)-2.39
52-week high33.20
52-week low10.47
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees48